An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
This study has been completed.
Sponsor:
BioWest Therapeutics Inc
Information provided by:
BioWest Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00292084
First received: February 13, 2006
Last updated: January 17, 2008
Last verified: January 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2007 |
| Estimated Primary Completion Date: | No date given |